39977-41-8 Usage
Uses
Used in Pharmaceutical Industry:
5-(HydroxyMethyl)picolinic acid is used as a pharmaceutical compound for its antioxidant and chelating properties, which may contribute to the development of new drugs and therapies.
Used in Synthesis of Coordination Complexes:
In the field of coordination chemistry, 5-(HydroxyMethyl)picolinic acid is used as a ligand in the synthesis of coordination complexes, which can have various applications in catalysis, materials science, and medicinal chemistry.
Used in Metal-Based Drug Development:
5-(HydroxyMethyl)picolinic acid is utilized in the development of metal-based drugs, leveraging its chelating properties to form stable complexes with metal ions, potentially enhancing the therapeutic efficacy of these drugs.
Used in Treatment of Metal Ion Imbalance Conditions:
5-(HydroxyMethyl)picolinic acid is studied for its potential role in treating conditions related to metal ion imbalances in the body, such as those involving iron, copper, or zinc, due to its ability to chelate and modulate metal ion levels.
Used in Research and Biochemistry:
In the realm of scientific research and biochemistry, 5-(HydroxyMethyl)picolinic acid serves as a subject of interest for further exploration, with potential applications in understanding and addressing various biological processes and diseases associated with metal ion homeostasis.
Check Digit Verification of cas no
The CAS Registry Mumber 39977-41-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,9,9,7 and 7 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 39977-41:
(7*3)+(6*9)+(5*9)+(4*7)+(3*7)+(2*4)+(1*1)=178
178 % 10 = 8
So 39977-41-8 is a valid CAS Registry Number.
39977-41-8Relevant academic research and scientific papers
Sulfonamides
-
Page/Page column 40, (2010/02/15)
The invention relates to compounds of the general formula in which R1, R2, R3, R4, R2′, R3′, R4′, R5, and X is —CHR— are as defined in the specification. The invention also provides pharmac
N-heterocyclic retinoic acid analogues
-
, (2008/06/13)
A compound of the formula: STR1 where X is STR2 and R is hydroxy, or an alkoxy with 0 or 1 hydroxy substituent, or aroxy with 0 or 1 hydroxy substituent, or alkoxy monosubstituted phenoxy, or NR 1 R 2 where R 1 is hydrogen, or an alkyl or aryl with 0 or 1 hydroxy substituent, and R 2 is an alkyl or aryl with 0 or 1 hydroxy substituent. These compounds are useful as chemopreventive agents for inhibiting tumor promotion in ephithelial cells and for treating nonmalignant skin disorders.
Aromatic Retinoic Acid Analogues. 2. Synthesis and Pharmacological Activity
Dawson, Marcia I.,Chan, Rebecca,Hobbs, Peter D.,Chao, Wan-ru,Schiff, Leonard J.
, p. 1282 - 1293 (2007/10/02)
Aromatic analogues of (E)-1-(4-carboxyphenyl)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)butadiene (1b) and its ethyl ester (1a) were synthesized as potential chemopreventive agents for the treatment of epithelial cancer and such skin diseases as psoriasis and cystic acne.The phenyl ring of 1 was replaced by 2-fluorophenyl, 2-methoxyphenyl, thienyl, furanyl, and pyridyl groups.The 1-fluorobutadiene analogue of 1 was also synthesized.With exception for the furanyl analogue, these compounds demonstrated good activity in reversing keratinization in hamster tracheal organ culture and in inhibiting the induction of ornithine decarboxylase in mouse epidermis by a tumor promoter.
